Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Organic Letters|June 22, 2018
Selective, Catalytic, and Metal-Free Coupling of Electron-Rich Phenols and Anilides Using Molecular Oxygen as Terminal OxidantLuis Bering, Melina Vogt, Felix M Paulussen, et al.
Frontiers in Chemistry|July 14, 2023
Development of the first geldanamycin-based HSP90 degradersSilas Wurnig, Melina Vogt, Julian Hogenkamp, et al.
Scientific Reports|May 21, 2025
Identification of non-charged 7.44 analogs interacting with the NHR2 domain of RUNX1-ETO with improved antiproliferative effect in RUNX-ETO positive cellsMohanraj Gopalswamy, David Bickel, Niklas Dienstbier, et al.
ACS Medicinal Chemistry Letters|July 14, 2026
Targeting Histone Acetyltransferases EP300/CBP by Novel Proline-Based PROTAC DegradersKathrin Tan, Melina Vogt, Katerina Schaal, et al.
RSC Medicinal Chemistry|December 22, 2022
A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2Shubhendu Palei, Jörn Weisner, Melina Vogt, et al.
RSC Medicinal Chemistry|February 23, 2024
Correction: A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2Shubhendu Palei, Jörn Weisner, Melina Vogt, et al.
Journal of Medicinal Chemistry|December 6, 2022
Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic ActivityLaura Sinatra, Jing Yang, Julian Schliehe-Diecks, et al.
Molecular Cancer|August 15, 2023
Unleashing T cell anti-tumor immunity: new potential for 5-Nonloxytryptamine as an agent mediating MHC-I upregulation in tumorsPaweł Stachura, Wei Liu, Haifeng C Xu, et al.
Biochemical Pharmacology|September 17, 2023
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic LeukemiaAthanasios Oikonomou, Luigia Valsecchi, Manuel Quadri, et al.
Cell Death & Disease|December 23, 2025
Small-molecule inhibitor of C‑terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cellsCéline David, Yadong Sun, Vitalij Woloschin, et al.
Pageof 2